Cipla Share Price
- All
- News
-
Why Are Pharma Stocks Rising?
The recent decline in the stock market has unnerved investors and traders alike. But pharma stocks are rising. Find out why and other implications.
-
Here's Why Cipla Share Price Is Rising
Pharma stocks are in focus amid renewed fears of Covid outbreaks and have rallied between 5-15% in the past couple of days.
-
5 Promoters Who Sold Their Holding Before The Stock Market Selloff
As economic realities of high inflation and slowing growth set in, the BSE Sensex dropped more than 10% since its January 2022 peak
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Cipla Hits Record High On Pact To Import Moderna's Covid Vaccine
Cipla shares have so far this year surged 22 per cent compared with 10 per cent gain in the Sensex.
-
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges
-
Cipla Launches Covid-19 Detection Test Kit ; Shares Gain
Cipla launched ViraGen which is a real-time detection kit approved by the ICMR (Indian Council of Medical Research) and is based on multiplex PCR technology.
-
Cipla Gains Nearly 5% On Settlement of US Patent Litigation
Cipla share price jumps 5%: The pharma major has announced settlement of its patent litigation with Celgene Corporation, a wholly-owned subsidiary of Bristol Myers Squibb, in the United States
-
Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US
The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.
-
Cipla Extends Gains For Second Straight Day On Strong June Quarter Earnings
On Friday, the company had reported a net profit of Rs 577.91 crore in the quarter ended June 30, marking a jump of 20.85 per cent compared to the corresponding period a year ago.
-
Cipla Hits Record High After Strong June Quarter Earnings
Cipla Share Price: By 11:22 am, 6.88 lakh Cipla shares had changed hands on the BSE, as against an average of 3.49 lakh over the past two weeks.
-
Cipla Gets Regulatory Nod To Make Gilead's COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
-
Cipla Shares Fall 6% After US Regulator's Warning Letter On Goa Facility
Cipla Share Price: Cipla said it will work closely with the US Food and Drug Administration (FDA) to comprehensively address all the observations.
-
Cipla Profit Rises 6% To Rs 478 Crore In June Quarter
Cipla's revenue from its pharmaceuticals business increased 1.22 per cent to Rs 3,959.93 crore in the quarter ended June 30.
-
Sensex Closes 176 Points Lower, Nifty Gives Up 10,200 Amid Choppy Trade: 10 Things To Know
Stock markets reversed early gains on Tuesday as losses in energy and metal stocks offset strength in IT shares. BSE benchmark index Sensex shed 176 points, or 0.5 per cent, to end at 33,891, while NSE's Nifty settled just shy of 10,200, down 52 points from the previous close. Investors turned cautious a day after key indices rose around 2 per cent...
-
Why Are Pharma Stocks Rising?
The recent decline in the stock market has unnerved investors and traders alike. But pharma stocks are rising. Find out why and other implications.
-
Here's Why Cipla Share Price Is Rising
Pharma stocks are in focus amid renewed fears of Covid outbreaks and have rallied between 5-15% in the past couple of days.
-
5 Promoters Who Sold Their Holding Before The Stock Market Selloff
As economic realities of high inflation and slowing growth set in, the BSE Sensex dropped more than 10% since its January 2022 peak
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Cipla Hits Record High On Pact To Import Moderna's Covid Vaccine
Cipla shares have so far this year surged 22 per cent compared with 10 per cent gain in the Sensex.
-
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges
-
Cipla Launches Covid-19 Detection Test Kit ; Shares Gain
Cipla launched ViraGen which is a real-time detection kit approved by the ICMR (Indian Council of Medical Research) and is based on multiplex PCR technology.
-
Cipla Gains Nearly 5% On Settlement of US Patent Litigation
Cipla share price jumps 5%: The pharma major has announced settlement of its patent litigation with Celgene Corporation, a wholly-owned subsidiary of Bristol Myers Squibb, in the United States
-
Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US
The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.
-
Cipla Extends Gains For Second Straight Day On Strong June Quarter Earnings
On Friday, the company had reported a net profit of Rs 577.91 crore in the quarter ended June 30, marking a jump of 20.85 per cent compared to the corresponding period a year ago.
-
Cipla Hits Record High After Strong June Quarter Earnings
Cipla Share Price: By 11:22 am, 6.88 lakh Cipla shares had changed hands on the BSE, as against an average of 3.49 lakh over the past two weeks.
-
Cipla Gets Regulatory Nod To Make Gilead's COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
-
Cipla Shares Fall 6% After US Regulator's Warning Letter On Goa Facility
Cipla Share Price: Cipla said it will work closely with the US Food and Drug Administration (FDA) to comprehensively address all the observations.
-
Cipla Profit Rises 6% To Rs 478 Crore In June Quarter
Cipla's revenue from its pharmaceuticals business increased 1.22 per cent to Rs 3,959.93 crore in the quarter ended June 30.
-
Sensex Closes 176 Points Lower, Nifty Gives Up 10,200 Amid Choppy Trade: 10 Things To Know
Stock markets reversed early gains on Tuesday as losses in energy and metal stocks offset strength in IT shares. BSE benchmark index Sensex shed 176 points, or 0.5 per cent, to end at 33,891, while NSE's Nifty settled just shy of 10,200, down 52 points from the previous close. Investors turned cautious a day after key indices rose around 2 per cent...
